NRG Oncology

We are excited to be a part of #ASCO21! NRG has 12 presentations, including 4 oral abstracts (2 at the Plenary Session). Be sure to follow our official #SoMe ambassadors as they share their insights during the @ASCO Virtual Meeting! @VonettaMW @JamesBatesMD @dsmgyo @pashtoonkasi

All NRG Operations offices, SDMCs, Biospecimen Banks, Serum Bank, & McKesson, will be closed today, Monday, May 31 in observance of Memorial Day. As you celebrate this weekend, please take a moment to honor those who have served and continue to serve to keep us safe. Thank you.

NRG Oncology Summer Meeting Goes Virtual! #NRG2021 Read more: http://ow.ly/8Gm150EXQw0

Be sure to check out the list of #ASCO21 presentations and posters by NRG Oncology researchers that is now posted on the NRG Oncology website: http://ow.ly/1evF50EXM5R

Looking at the big picture of Small Cell Lung Cancer is important as referenced in this great read from Cure Magazine http://bit.ly/3s46orU We are currently working on our research in SCLC, including a currently active trial for immunotherapy with Principal Investigator, Dr. Kristin Higgins http://bit.ly/TreatmentsSCLC @Winship Cancer Institute of Emory University

Happy Holidays from all of us at NRG Oncology!

Just a reminder that many of our locations are closing early today and will be closed through the weekend in observance of the Christmas holiday. Please refer to the memos posted on our website for details: http://ow.ly/y7X950CS4zo

Happy Holidays! We wish you joy and peace for this holiday season and throughout the New Year! http://ow.ly/V7QA50CS1QU

NRG Oncology Weekly Broadcast for December 21, 2020: http://ow.ly/wkqh50CRjlH

November is #LungCancerAwarenessMonth - please pay attention to symptoms and speak to your doctor about preventative screening. We have study webpages available for 2 open NRG #LungCancer #clinicaltrials - Learn more: https://www.nrgoncology.org/LU003 & http://bit.ly/Lung-Awareness

What do ALK+ lung cancer patients need to know about NRG-LU003? We have some fast facts available for this clinical trial. Use our study webpage to provide patients with more information: https://www.nrgoncology.org/LU003 National Cancer Institute

The NRG Oncology Semiannual Meeting #NRG2021 planned for January 28-30, 2021 will be held virtually as a result of the continuing health threat and restrictions associated with the ongoing COVID-19 pandemic. Read more: http://ow.ly/r24o50C61cg

Today is the last day to submit an application for membership on the CTN Subcommittee, the CRA Subcommittee, and all Working Groups through the NRG Protocol Support Committee. Click here for more information: http://ow.ly/qDUK50BZLBS

Here's your one stop shop for all NRG press releases from #ASTRO20! If you missed our email broadcast, be sure to check it out here. http://ow.ly/2IMD50C5hQX Not on our email list? Contact us at [email protected] to get added to our mailing list. #NRGatASTRO20

PRESS RELEASE: Follow Up Results on First Multicenter Trial to Report Outcomes of Salvage Low Dose Radiotherapy Brachytherapy after External Beam Radiotherapy for Prostate Cancer http://ow.ly/geyr50C5bdx #ProstateCancer #NRGatASTRO20

PRESS RELEASE: NRG Oncology Study on Treatment for Advanced Endometrial Cancer Chosen as ‘Editor’s Choice’ in Journal of Clinical Oncology http://ow.ly/XDSo50C57pi @UTSWNews @dsmgyo #EndometrialCancer #GYN

PRESS RELEASE: NRG-RTOG 0617 Validates ERCC1/2 Genotypic Signature as a Radiosensitivity Biomarker for Tumor and Normal Tissues in Non-Small Cell Lung Cancer Patients http://ow.ly/6UDR50C58qW #NRGatASTRO20 #ASTRO20 #NSCLC @hkumed @CWRUSOM

PRESS RELEASE: Updated Analysis of NRG-RTOG 9813 Indicates IDH1/2 Mutation Status is Statistically Associated with Better Overall and Progression-free Survival for Patients with Anaplastic Astrocytoma http://ow.ly/Qylj50C5443 #NRGatASTRO20 #ASTRO20

Dr. Crook presents on salvage low dose rate prostate brachytherapy and the clinical outcomes of NRG-RTOG 0526 for local recurrence after external beam RT during the Clinical Trials Session at #ASTRO20. #NRGatASTRO20 #prostatecancer

Dr. Kong presents on NRG-RTOG 0617 : externally validating blood cell ERCC1/2 genotypic signature as radiosensitivity biomarker for both tumor & normal tissue for individualized dose prescription during the Clinical Trials Session at #ASTRO20. #NRGatASTRO20

Last day of #ASTRO20: Check out these #NRGatASTRO20 presentations for today!

Dr. Fleming presents a late-breaking update on the prognostic significance of IDH1/2 mutation and MGMT promoter methylation status in NRG-RTOG 9813 at #ASTRO20. The presentation is available today! #NRGatASTRO20